Lecture: Clinical perspectives: Non-AR therapeutic targets in CRPC

Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (for)

Debate: Will chemotherapy continue to be standard treatment for symptomatic mCRPC in the era of novel agents? (against)

Lecture: Clinical Perspectives: How far are we from personalising treatment for prostate cancer patients?

Lecture: Future strategies and targets for prostate cancer

Surgical strategies available for renal cell carcinoma with inferior vena cava invasion

Use of robotics in kidney cancer surgery

Work and history of the Kidney Cancer Association

Intratumour heterogeneity in renal and lung cancer

Kidney cancer treatment ten years from now

Role of AORTIC in dealing with rising cancer rates in Africa

Biomarker development for ipilimumab and prostate GVAX treatment